XOMA Royalty (XOMA) Share-based Compensation (2010 - 2026)

XOMA Royalty (XOMA) reported Share-based Compensation of $1.4 million for Q1 2026, up 483.33% on a YoY basis from $240000.0 in Q1 2025, and up 159.02% sequentially from -$2.4 million in Q4 2025.

XOMA Royalty (XOMA) Share-based Compensation (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 17 years of Share-based Compensation data on file, last reported at $1.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 483.33% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 89.55% YoY), and the FY2025 full-year result was $3.0 million, down 71.04% from the prior year.
  • Share-based Compensation advanced to $1.4 million in Q1 2026, from -$2.4 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $7.9 million in Q4 2024 to a low of -$2.4 million in Q4 2025.
  • A 5-year average of $1.4 million and a median of $1.1 million in 2022 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation plunged 13677.78% in 2022 and surged 984.55% in 2024, its largest moves.
  • Tracing XOMA's Share-based Compensation over 5 years: stood at -$1.2 million in 2022, then jumped by 316.78% to $2.6 million in 2023, then surged by 197.58% to $7.9 million in 2024, then slumped by 130.09% to -$2.4 million in 2025, then jumped by 159.02% to $1.4 million in 2026.
  • Business Quant data shows XOMA's Share-based Compensation at $1.4 million in Q1 2026, -$2.4 million in Q4 2025, and $700000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - 1.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.40 Mn
Mar 31, 2026 1.40 Mn
Dec 31, 2025 -2.37 Mn
Dec 31, 2025 -2.37 Mn
Jun 30, 2025 700,000.00
Jun 30, 2025 700,000.00
Mar 31, 2025 240,000.00
Mar 31, 2025 240,000.00
Dec 31, 2024 7.88 Mn
Dec 31, 2024 7.88 Mn
Sep 30, 2024 2.59 Mn
Sep 30, 2024 2.59 Mn
Jun 30, 2024 2.69 Mn
Jun 30, 2024 2.69 Mn
Mar 31, 2024 1.33 Mn
Mar 31, 2024 1.33 Mn
Dec 31, 2023 2.65 Mn
Dec 31, 2023 2.65 Mn
Sep 30, 2023 2.72 Mn
Sep 30, 2023 2.72 Mn